Fulgent Genetics: Q1 Earnings Insights - Fulgent Genetics (NASDAQ:FLGT)

Fulgent Genetics FLGT reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Fulgent Genetics beat estimated earnings by 31.61%, reporting an EPS of $5.08 versus an estimate of $3.86.

Revenue was down $39.16 million from the same period last year.

Last quarter the company beat on EPS by $0.87 which was followed by a 2.16% increase in the share price the next day.

Here's a look at Fulgent Genetics's past performance:

Quarter	Q4 2021	Q3 2021	Q2 2021	Q1 2021
EPS Estimate	2.61	3.25	2.81	5.86
EPS Actual	3.48	4.05	2.55	6.59
Revenue Estimate	191.10M	264.00M	197.34M	321.51M
Revenue Actual	251.67M	227.87M	153.62M	359.43M

To track all earnings releases for Fulgent Genetics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.